Ivermectin, Fenbendazole and Mebendazole Cancer Treatment Research
Ivermectin and Fenbendazole in Cancer Care: A Functional Medicine Breakthrough
As cancer diagnoses rise globally, the urgency for innovative, effective, and supportive therapies grows stronger. A peer-reviewed study has highlighted a groundbreaking protocol combining ivermectin, fenbendazole, and natural compounds such as Vitamin E, curcumin, and CBD. These elements, when used together, demonstrate significant potential in supporting cancer care.The Study: A Synergistic Approach to Cancer Care
The research reveals the combined effects of ivermectin, fenbendazole, and complementary compounds in addressing cancer at multiple levels. While traditionally known as antiparasitic drugs, ivermectin and fenbendazole, when used together, showed potential to modulate cancer pathways and support the body’s natural healing mechanisms.Key Findings from the Study
1. Immune System Modulation: The protocol enhanced the immune system’s ability to detect and target cancer cells.
2. Cellular Repair: The combination supported cellular repair processes, mitigating damage that contributes to cancer progression.
3. Anti-Cancer Activity: Together, ivermectin and fenbendazole appeared to limit cancer cell proliferation, enhancing the effectiveness of the treatment protocol.
The Hybrid Orthomolecular Cancer Protocol: 7 therapeutic recommendations, consisting of orthomolecules, drugs, and additional therapies
- Low-grade cancers: Dose of 0.5mg/kg, 3x per week (Guzzo, et al., 2002).
- Intermediate-grade cancers: Dose of 1mg/kg, 3x per week (Guzzo, et al., 2002).
- High-grade cancers: Dose from 1 mg/kg/day (de Castro, et al., 2020) to 2 mg/kg/day (Guzzo, et al., 2002).
- Low-grade cancers: Mebendazole: Dose of 200 mg/day (Dobrosotskaya, et al., 2011).
- Intermediate-grade cancers: Mebendazole: Dose of 400 mg/day (Chai, et al., 2021).
- High-grade cancers: Mebendazole dose of 1,500 mg/day (Son, et al., 2020) or Fenbendazole 1,000 mg 3x per week (Chiang, et al., 2021).
Everyone’s situation is different, however, it is important to arm yourself with medical knowledge that cancer doctors (Oncologists) may simply not give you.
Whether you’re living with cancer or a survivor, talk to your doctor to determine the best treatment for you.
How Functional Medicine Supports Cancer Care
1. Immune Optimization: Strengthening the immune system is central to our functional medicine protocols. The study’s emphasis on immune modulation reflects the importance of this approach in cancer prevention and recovery.
2. Personalized Treatment Plans: We tailor protocols to each patient, incorporating research-backed therapies like ivermectin and fenbendazole alongside dietary changes, lifestyle adjustments, and advanced supplements.
3. Synergistic Interventions: Functional medicine thrives on integrative solutions. The study’s use of Vitamin E, curcumin, and CBD exemplifies how combining therapies enhances overall effectiveness and supports whole-body healing.
The Role of Complementary Compounds in the Protocol
The study’s protocol emphasizes the importance of complementary compounds, which work alongside ivermectin and fenbendazole to enhance therapeutic outcomes:- Vitamin E: Reduces oxidative stress and protects cells from damage.
- Curcumin: Offers anti-inflammatory and antioxidant properties, with emerging evidence of its role in slowing cancer progression.
- CBD (Cannabidiol): Supports immune health, reduces inflammation, and alleviates pain.
Find Integrative Oncologists in USA, Mexico, Europe or Asia
While the potential anti-cancer properties of fenbendazole, ivermectin and mebendazole are intriguing, it’s crucial to approach with caution.Consulting with an integrative healthcare expert is key to crafting a protocol tailored to your unique health requirements.
Conclusion
While clinical trials remain limited, emerging studies suggest promising applications across multiple cancer types.
Patients should consult healthcare professionals before considering this protocol.
Read More: This article is part of the Winning the War on Cancer series.
Related:
New & Improved Joe Tippens Protocol
- Ivermectin (24 mg, 6 days a week) or in the case of severe aggresive cancers up to 1mg/kg/day (6 days a week).
- Mebendazole (Dose of 200 - 400 mg/day) or Fenbendazole, commonly taken at 300 mg for six days a week, with doses increasing to up to 1 gram in cases of aggressive cancers.
- Vitamin D (62.5 mcg [2500 IU] seven days a week).
- Bio-Available Curcumin (600 mg per day, 7 days a week).
- Enhanced absorption Berberine (500 mg per day) to starve your cancer of sugar.
- Diet and Lifestyle: Eliminate sugar consumption as supported by the BMJ 2023 umbrella review, which recommends reducing free and added sugars to below 25 g/day and limiting sugar-sweetened beverages to less than one serving per week to reduce adverse health effects. Adopt a whole-food diet and avoid ultra-processed foods, as recommended by the BMJ 2024 guidelines. Additionally, prioritise adequate quality sleep and effective stress management to support overall health.
- Please note that this protocol now includes the vital Vitamin D addition, with the one day off for the fenbendazole administration. This protocol represents the most comprehensive and cutting edge repurposed drug and vitamin treatment approach to date.
- If you are taking ivermectin and mebendazole, you might not need fenbendazole. Consult your doctor.
- Vitamin E: Removed from the protocol (Joe Tippens, July 22, 2020) due to interactions (e.g., with blood thinners).
Researched and approved by Dr. Peter McCullough.
- Prescribed by licensed medical professionals
- Compounded and dispensed by a licensed US-based pharmacy
- Approved for human use


Comments
Post a Comment